Senomyx Inc (SNMX) 4.38 $SNMX SENOMYX ANNOUNCES APPROVAL

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Senomyx Inc (SNMX) 4.38 $SNMX

SENOMYX ANNOUNCES APPROVAL OF BITTERMYX® BB68 AND SWEETMYX® SR96 FLAVOR INGREDIENTS IN CHINA
PR Newswire - Wed Aug 31, 7:30AM CDT
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor industries, announced today that its flavor ingredients Sweetmyx® SR96 (S9632) and Bittermyx® BB68 (S6821) have been approved for use by the Food and Drug Administration of the People's Republic of China. Sweetmyx SR96 is used to boost the sweet taste of products allowing food and beverage companies to significantly reduce sugar while maintaining the same taste to create lower calorie offerings. Bittermyx BB68 is used to reduce the bitterness of certain ingredients and can be used to reduce bitter taste associated with hydrolyzed soy and whey proteins, menthol, caffeine, cocoa, and Rebaudioside A (stevia) for use in food, beverage, OTC and oral care products.
SNMX: 4.38 (-0.21)

Senomyx to Webcast Corporate Presentation at the Liolios Group 5th Annual Gateway Conference on September 7, 2016
PR Newswire - Tue Aug 30, 7:30AM CDT
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor industries, announced today that John Poyhonen, the Company's President and Chief Executive Officer, and Tony Rogers, Senior Vice President and Chief Financial Officer, will present an overview of Senomyx's technology and programs on Wednesday, September 7, at 2:30 p.m. Pacific Time during the Liolios Group 5th Annual Gateway Conference. The conference is taking place at the Four Seasons Hotel in San Francisco, CA. During the presentation, Mr. Poyhonen and Mr. Rogers will discuss corporate developments including the Company's pipeline of novel flavor ingredients and its business strategy.
SNMX: 4.38 (-0.21)

Senomyx (SNMX) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 1:30AM CDT
As of late, it has definitely been a great time to be an investor in Senomyx Inc. (SNMX)
SNMX: 4.38 (-0.21)

SENOMYX ANNOUNCES SECOND QUARTER 2016 FINANCIAL RESULTS
PR Newswire - Thu Jul 28, 3:05PM CDT
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the second quarter ended June 30, 2016. Total revenues for the second quarter 2016 were $6.6 million including $2.3 million in commercial revenues.
SNMX: 4.38 (-0.21)

Senomyx (SNMX) in Focus: Stock Adds 7.3% in Session
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:45AM CDT
Senomyx Inc. (SNMX) was a big mover last session, as the company saw its shares rise over 7% on the day.
BGS: 47.48 (+0.30), SNMX: 4.38 (-0.21)

Will Senomyx (SNMX) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 8:16AM CDT
As of late, it has definitely been a great time to be an investor in Senomyx Inc. (SNMX).
SNMX: 4.38 (-0.21)

Senomyx reports 1Q loss
Automated Insights - Thu Apr 28, 4:19PM CDT
SAN DIEGO (AP) _ Senomyx Inc. (SNMX) on Thursday reported a loss of $2.4 million in its first quarter.
SNMX: 4.38 (-0.21)

SENOMYX ANNOUNCES FIRST QUARTER 2016 FINANCIAL RESULTS
PR Newswire - Thu Apr 28, 3:01PM CDT
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the first quarter ended March 31, 2016. Total revenues for the first quarter 2016 were $6.3 million including $2.1 million in commercial revenues.
SNMX: 4.38 (-0.21)

Senomyx, Inc. First Quarter 2016 Earnings Conference Call Scheduled for April 28, 2016
GlobeNewswire - Mon Apr 18, 3:15PM CDT
Senomyx, Inc. (NASDAQ:SNMX) will release its financial results for the first quarter ended March 31, 2016 on Thursday, April 28, 2016, after the close of the U.S. financial markets. The Company will also host a conference call with a live Internet broadcast that will provide a corporate update and a review of its first quarter results on the same day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
SNMX: 4.38 (-0.21)

SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 15TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
PR Newswire - Thu Mar 31, 4:00PM CDT
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and flavor industries, announced today that John Poyhonen, the Company's President and Chief Executive Officer, and Tony Rogers, Senior Vice President and Chief Financial Officer, will present an overview of Senomyx's technology and business model on Wednesday, April 13, at 11:20 a.m. Eastern Time (8:20 a.m. Pacific Time) during the 15th Annual Needham Healthcare Conference. The conference is taking place at the Westin Grand Central Hotel in New York, NY. During the presentation, Mr. Poyhonen and Mr. Rogers will discuss corporate developments including the Company's novel flavor ingredients and its business strategy.
SNMX: 4.38 (-0.21)

BUYINS.NET: ECH, GRU, SNMX, EUO, FNGN Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jan 27, 6:37AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares MSCI Chile Investable Market Index Fund (NYSE:ECH), ELEMENTS - MLCX GRAINS (NYSE:GRU), Senomyx Inc (NASDAQ:SNMX), Eurocontrol Technics Group Inc (NYSE:EUO), Financial Engines Inc (NASDAQ:FNGN) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
FNGN: 31.97 (-0.35), ECH: 36.52 (-0.66), EUO: 24.06 (-0.06), SNMX: 4.38 (-0.21), GRU: 3.67 (+0.03)

SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 18TH ANNUAL NEEDHAM GROWTH CONFERENCE
PR Newswire - Fri Jan 08, 3:15PM CST
Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients for the food, beverage, and flavor industries, announced today that John Poyhonen, the Company's President and Chief Executive Officer, and Tony Rogers, Senior Vice President and Chief Financial Officer, will present an overview of Senomyx's technology and programs on Wednesday, January 13, at 1:30 p.m. Eastern Time (10:30 a.m. Pacific Time) during the 18th Annual Needham Growth Conference. The conference is taking place at the New York Palace Hotel in New York, NY. During the presentation, Mr. Poyhonen and Mr. Rogers will discuss corporate developments including the Company's pipeline of novel flavor ingredients and its business strategy.
SNMX: 4.38 (-0.21)

Stock to Watch: Senomyx Up 6.3% (SNMX)
Comtex SmarTrend(R) - Wed Dec 23, 12:48PM CST
Senomyx (NASDAQ:SNMX) is one of today's best performing low-priced stocks, up 6.3% to $4.06 on 1.0x average daily volume. Senomyx has traded 266,000 shares thus far today, vs. average volume of 255,000 shares per day. The stock has outperformed the Dow (6.3% to the Dow's 0.6%) and outperformed the S&P 500 (6.3% to the S&P's 0.8%) during today's trading.
SNMX: 4.38 (-0.21)

Identifying Opportunity, Placing Risk - Analyst Notes on Five Star Quality Care, Senomyx, Ring Energy and Sophiris Bio
ACCESSWIRE - Fri Dec 18, 6:30AM CST
NEW YORK, NY / ACCESSWIRE / December 18, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Five Star Quality Care Inc. (NYSE: FVE), Senomyx Inc. (NASDAQ: SNMX), Ring Energy Inc. (NYSE: REI) and Sophiris Bio Inc. (NASDAQ: SPHS). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
FVE: 2.12 (+0.01), SPHS: 3.05 (+0.07), REI: 9.92 (-0.22), SNMX: 4.38 (-0.21)

BUYINS.NET: SNMX, USG, E, GB, SXL, AT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Dec 08, 7:10AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Senomyx Inc (NASDAQ:SNMX), USG Corp (NYSE:USG), Eni SpA (NYSE:E), Greatbatch Inc (NYSE:GB), Slam Exploration Ltd (NYSE:SXL), ATLANTIC POWER CORP (NYSE:AT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
AT: 2.58 (+0.01), E: 30.20 (+0.07), GB: 30.93 (+0.63), USG: 27.43 (-1.37), SNMX: 4.38 (-0.21), SXL: 29.60 (-0.31)

Traders Get Bullish on Shares of Senomyx, Shares Up 6.3% (SNMX)
Comtex SmarTrend(R) - Mon Nov 30, 11:41AM CST
Senomyx (NASDAQ:SNMX) is one of today's best performing low-priced stocks, up 6.3% to $4.74 on 1.3x average daily volume. Senomyx has traded 336,000 shares thus far today, vs. average volume of 253,000 shares per day. The stock has outperformed the Dow (6.3% to the Dow's -0.2%) and outperformed the S&P 500 (6.3% to the S&P's -0.2%) during today's trading.
SNMX: 4.38 (-0.21)

Where Opportunity is Found - Research on Ballard Power Systems, Mattson Technology, Senomyx and EMCORE
ACCESSWIRE - Fri Nov 20, 6:55AM CST
NEW YORK, NY / ACCESSWIRE / November 20, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ballard Power Systems Inc. (NASDAQ: BLDP), Mattson Technology Inc. (NASDAQ: MTSN), Senomyx Inc. (NASDAQ: SNMX) and EMCORE Corp. (NASDAQ: EMKR). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
BLDP: 2.15 (+0.07), EMKR: 4.96 (-0.04), MTSN: 3.60 (unch), SNMX: 4.38 (-0.21)

Senomyx, Inc. Third Quarter 2015 Earnings Conference Call Scheduled for October 29, 2015
GlobeNewswire - Thu Oct 22, 7:30AM CDT
Senomyx, Inc. (NASDAQ:SNMX) will release its financial results for the third quarter ended September 30, 2015 on Thursday, October 29, 2015, before the opening of the U.S. financial markets. The Company will also host a conference call with a live Internet broadcast that will provide a corporate update and a review of its third quarter results on the same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time).
SNMX: 4.38 (-0.21)

Immune Therapeutics Adds Experienced New Board Member Saiid Zarrabian
ACCESSWIRE - Wed Oct 07, 5:18PM CDT
ORLANDO, FL / ACCESSWIRE / October 7, 2015 / Immune Therapeutics, Inc., a U.S. public company (OTCQB: IMUN), announces the appointment of Saiid Zarrabian as Immune's newest board member.
SNMX: 4.38 (-0.21)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 165

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 58

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 148

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 247

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 89

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading

Top 5 Most Recently Viewed Articles

Verizon Secures $66 Million EIS Partnership with Coast Guard

Updated Category News Views 283

Verizon Awarded $66 Million Enterprise Infrastructure Solutions Contract In a significant development, Verizon Business has been awarded a substantial contract valued at up to $66 million by the U.S. Coast Guard. This eight-year Enterprise Infrastructure Solutions (EIS) task order represents a robust commitment to enhancing the Coast Guard's communication and operational...

Continue Reading
Icelandic Glacial Becomes Laver Cup 2025's Official Water

Updated Category News Views 168

Icelandic Glacial to Hydrate Laver Cup 2025 Attendees Icelandic Glacial™, recognized for its exceptional quality and purity, has been designated as the Official Water for the highly anticipated Laver Cup 2025. This prestigious tournament is scheduled to take place at the Chase Center, showcasing top-tier men's tennis. A Perfect Fit for a Grand Event Coming from the...

Continue Reading
Dick's Sporting Goods Shows Promise for Q3 Amid Market Trends

Updated Category News Views 196

Dick's Sporting Goods Anticipates Strong Q3 Results Dick's Sporting Goods Inc. (NYSE: DKS) is gearing up for its fiscal third-quarter earnings report, creating buzz among investors eager to understand how the retailer is managing consumer demand and its recent strategic moves. As the company prepares to disclose its earnings, the market remains cautiously optimistic,...

Continue Reading
HyOrc Corporation Charts New Path with Green Fuel Innovations

Updated Category News Views 165

HyOrc Corporation's Strategic Market Transformation HyOrc Corporation (OTCID: HYOR) is making significant strides in the clean energy sector with a recent change in its trading symbol on the OTC markets. This evolution reflects not only a fresh identity but also the dynamic advancements the company is achieving in green fuel technologies and hydrogen mobility....

Continue Reading
Exploring Nature Through Art: BlackBook's New Exhibition

Updated Category News Views 227

BlackBook Presents Unveils a Unique Art Exhibition BlackBook Presents is set to embark on an exciting journey with its upcoming art exhibition titled Mother Nature in the Bardo. This innovative presentation, in collaboration with UNESCO's GEM Report, aims to foster meaningful discussions about art, culture, and their profound connection to environmental issues. Through an...

Continue Reading